Chloraseptic Warming Sore Throat Lozenge
NDC Package 67172-017-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Chloraseptic Warming Sore Throat (benzocaine) lozenges is adults and children 3 years of age and over: Take 1 lozenge every 2 hours as needed. This formulation utilizes a lozenge delivery system. Marketed by Prestige Brands Holdings, Inc., this product is identified by NDC 67172-017 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
67172-017-02
Package Description
1 BLISTER PACK in 1 CARTON / 18 LOZENGE in 1 BLISTER PACK
Product Code
67172-017
11-Digit Billing Format
67172001702
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Chloraseptic Warming Sore Throat
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Lozenge - A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BENZOCAINE 15 mg/1
Pharmacologic Class
Usage Information
Adults and children 3 years of age and over: Take 1 lozenge every 2 hours as needed. Allow lozenges to dissolve slowly in the mouth. Children under 3 years of age: Consult a doctor or dentist. Adults and children 3 years of age and over: Take 1 lozenge every 2 hours as needed. Allow lozenges to dissolve slowly in the mouth. Children under 3 years of age: Consult a doctor or dentist.

Regulatory & Marketing

Labeler Name
Prestige Brands Holdings, Inc.
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67172-017-02 identifies a specific commercial package of 1 blister pack in 1 carton / 18 lozenge in 1 blister pack of Chloraseptic Warming Sore Throat, a human over the counter drug labeled by Prestige Brands Holdings, Inc.. This lozenge is formulated for oral use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Prestige Brands Holdings, Inc. on January 01, 2012. The current certification is valid through December 31, 2026.

How is this Prestige Brands Holdings, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67172001702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67172-017-02
11-Digit CMS (5-4-2)
67172-0017-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.